Table 2

Relative risks and 95% confidence intervals of myocardial infarction in each trial

Source

Male (%)

Non–fatal MI

Fatal MI

Fatal and non-fatal MI


WHS [26] (2005)

0

1.02 (0.83–1.25)

1.17 (0.54–2.52)

1.03 (0.84–1.25)

PPP [19] (2001)

42

0.69 (0.36–1.34)

0.68 (0.19–2.40)

0.69 (0.39–1.23)

ACBS [18] (1995)

45

1.71 (0.51–5.75)

NA

NA

ETDRS [13] (1992)

52

NA

NA

0.85(0.73–1.00)

SAPAT [24] (1992)

52

0.61 (0.43–0.87)

1.02 (0.50–2.07)

0.68 (0.50–0.92)

HOT [23] (1998)

53

NA

NA

0.85 (0.69–1.05)

Swedish cooperative [8] (1987)

62

0.88 (0.45–1.72)

1.00 (0.33– 3.05)

0.91 (0.52, 1.60)

EAFT [14] (1993)

63

0.94 (0.35–2.47)

0.90 (0.52–1.56)

0.91 (0.56–1.46)

SALT [11] (1991)

66

0.91 (0.59–1.41)

0.65 (0.36–1.16)

0.80 (0.57–1.13)

Canadian group study [17] (1985)

70

1.29 (0.49–3.36)

0.54 (0.22–1.31)

0.80 (0.43–1.48)

SPAF [12] (1991)

71

0.57 (0.19–1.70)

NA

NA

Danish cooperative [27] (1983)

73

0.25 (0.05–1.16)

0.67 (0.20–2.31)

0.43 (0.17–1.08)

UK–TIA [22] (1991)

73

0.86 (0.68–1.11)

1.01 (0.74–1.39)

0.92 (0.77–1.11)

PARIS [5] (1980)

77

0.68 (0.47–1.01)

0.79 (0.55–1.15)

0.74 (0.57–0.95)

GAAT [16] (1980)

78

0.63 (0.39–1.03)

0.58 (0.30–1.12)

0.61 (0.42–0.89)

Cardiff–II [21] (1979)

85

0.49 (0.33–0.75)

NA

NA

AMIS [6] (1980)

89

0.78 (0.63–0.96)

1.08 (0.89–1.31)

0.93 (0.81–1.07)

Cardiff–I [20] (1974)

100

0.68 (0.31–1.49)

NA

NA

CDPA [7] (1980)

100

0.86 (0.52–1.42)

NA

NA

VACS [25] (1983)

100

0.49 (0.29–0.81)

0.17 (0.02–1.42)

0.45 (0.28–0.74)

PHS [9] (1989)

100

0.61 (0.49–0.75)

0.38 (0.19–0.80)

0.58 (0.47–0.72)

RISC [10] (1990)

100

0.49 (0.33–0.73)

NA

NA

TPT [15] (1998)

100

0.68 (0.53–0.89)

1.13 (0.78–1.63)

0.81 (0.66–0.99)

Total

49

0.72 (0.64–0.81)

0.88 (0.75–1.03)

0.79 (0.72–0.87)


MI, myocardial infarction; NA, not available.

Yerman et al. BMC Medicine 2007 5:29   doi:10.1186/1741-7015-5-29

Open Data